- Home
- USA vs LMAT Comparison
USA vs LMAT Comparison
Compare USA & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USA
- LMAT
- Stock Information
- Founded
- USA 1986
- LMAT 1983
- Country
- USA United States
- LMAT United States
- Employees
- USA N/A
- LMAT N/A
- Industry
- USA Finance Companies
- LMAT Medical/Dental Instruments
- Sector
- USA Finance
- LMAT Health Care
- Exchange
- USA Nasdaq
- LMAT Nasdaq
- Market Cap
- USA N/A
- LMAT 1.9B
- IPO Year
- USA N/A
- LMAT 2006
- Fundamental
- Price
- USA $6.88
- LMAT $83.69
- Analyst Decision
- USA
- LMAT Buy
- Analyst Count
- USA 0
- LMAT 6
- Target Price
- USA N/A
- LMAT $100.80
- AVG Volume (30 Days)
- USA 880.5K
- LMAT 148.7K
- Earning Date
- USA 01-01-0001
- LMAT 08-05-2025
- Dividend Yield
- USA 9.66%
- LMAT 0.93%
- EPS Growth
- USA N/A
- LMAT 30.45
- EPS
- USA N/A
- LMAT 1.97
- Revenue
- USA N/A
- LMAT $226,256,000.00
- Revenue This Year
- USA N/A
- LMAT $13.88
- Revenue Next Year
- USA N/A
- LMAT $8.81
- P/E Ratio
- USA N/A
- LMAT $43.54
- Revenue Growth
- USA N/A
- LMAT 13.19
- 52 Week Low
- USA $5.62
- LMAT $71.42
- 52 Week High
- USA $7.09
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- USA 60.48
- LMAT 50.89
- Support Level
- USA $6.84
- LMAT $82.76
- Resistance Level
- USA $6.94
- LMAT $86.94
- Average True Range (ATR)
- USA 0.07
- LMAT 2.10
- MACD
- USA 0.01
- LMAT 0.18
- Stochastic Oscillator
- USA 82.20
- LMAT 47.92
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.